Publications Archives - Page 2 of 2

Technologies for Translational Imaging Using Generators in Oncology Short Running Title: Imaging and Oncology

Posted on: November 21st, 2007

Anti-Cancer Drug Discovery, 2007 https://cellpointweb.com/wp-content/uploads/2019/11/Schechter-MS.pdf

Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals.

Posted on: November 21st, 2004

current medical imaging reviews 2004 https://cellpointweb.com/wp-content/uploads/2019/11/EC-GA-68-Jan-2005.pdf

Assessment of Therapeutic Tumor Response Using 99mTc-Ethylenedicysteine-Glucosamine.

Posted on: November 4th, 2004

Cancer Biology Therapy & Radiopharmaceuticals 2004 https://cellpointweb.com/wp-content/uploads/2019/11/EC-Glucosamine-Nov-2004.pdf

Radiation Dosimetry of 99mTc-Labeled C225 in Patients with Squamous Cell Carcinoma of the Head and Neck.

Posted on: March 30th, 2004

epidermal growth factor receptor i meaning , 2004 https://cellpointweb.com/wp-content/uploads/2019/11/C-225-Oct-2004.pdf

Prognostication of Recovery in Patients With Acute Ischemic Stroke Through the Use of Brain SPECT With Technetium-99m Labeled Metronidazole

Posted on: November 21st, 2003

Link to read https://cellpointweb.com/wp-content/uploads/2019/11/Stroke-April-2003.pdf

Imaging with 99mTc ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents1 Radiology

Posted on: February 21st, 2003

Radiology 2003 https://cellpointweb.com/wp-content/uploads/2019/11/Radioilogy-Feb-2003.pdf

Assessment of Antiangiogenic Effect Using 99mTc-EC-Endostatin

Posted on: November 2nd, 2002

Cancer Biology Therapy & Radiopharmaceuticals 2002 https://cellpointweb.com/wp-content/uploads/2019/11/Endostatin-Nov-2002.pdf

Assessment of epidermal growth factor receptor with 99mTc ethylenedicysteine C225 monoclonal antibody.

Posted on: October 21st, 2002

Lippincott Williams & Wilkins 2003 https://cellpointweb.com/wp-content/uploads/2019/11/C-225-Jan-2003.pdf

In Vivo and In Vitro Measurement of Apoptosis in Breast Cancer Cells Using 99mTc-EC-Annexin V

Posted on: November 1st, 2001

Cancer Biology Therapy & Radiopharmaceuticals 2001 https://cellpointweb.com/wp-content/uploads/2019/11/annexin-Nov-1-2001.pdf

Noninvasive Assessment of Tumor Hypoxia with 99mTc Labeled Metronidazole

Posted on: February 2nd, 1999

Link to read https://cellpointweb.com/wp-content/uploads/2019/11/Metronidazole-1999.pdf

Cell>Point News & Publications

Diagnostic Imaging

Publications

Technologies for Translational Imaging Using Generators in Oncology Short Running Title: Imaging and Oncology

Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals.

Assessment of Therapeutic Tumor Response Using 99mTc-Ethylenedicysteine-Glucosamine.

Radiation Dosimetry of 99mTc-Labeled C225 in Patients with Squamous Cell Carcinoma of the Head and Neck.

Prognostication of Recovery in Patients With Acute Ischemic Stroke Through the Use of Brain SPECT With Technetium-99m Labeled Metronidazole

Imaging with 99mTc ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents1 Radiology

Assessment of Antiangiogenic Effect Using 99mTc-EC-Endostatin

Assessment of epidermal growth factor receptor with 99mTc ethylenedicysteine C225 monoclonal antibody.

In Vivo and In Vitro Measurement of Apoptosis in Breast Cancer Cells Using 99mTc-EC-Annexin V

Noninvasive Assessment of Tumor Hypoxia with 99mTc Labeled Metronidazole